Back to Search
JENNIFER BRIONES, MD
MD
Family Medicine Physician
NPI: 1386681443IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
35087403(OH)
CMS Specialties
PrimaryFAMILY PRACTICE
Education
OTHER
Class of 2000
Research & Publications (20)
Does reduced-intensity allogeneic transplantation confer a survival advantage to patients with poor prognosis chronic lymphocytic leukaemia? A case-control retrospective analysis.
PMID 19596701·Ann Oncol·2009
8-other
Lower respiratory tract respiratory virus infections increase the risk of invasive aspergillosis after a reduced-intensity allogeneic hematopoietic SCT.
PMID 19398963·Bone Marrow Transplant·2009
8-other
Emerging therapies for patients with advanced chronic lymphocytic leukaemia.
PMID 19643519·Blood Rev·2009
6-review
Beta2-microglobulin is a better predictor of treatment-free survival in patients with chronic lymphocytic leukaemia if adjusted according to glomerular filtration rate.
PMID 19388937·Br J Haematol·2009
8-other
Bcl-10 protein highly correlates with the expression of phosphorylated p65 NF-kappaB in peripheral T-cell lymphomas and is associated with clinical outcome.
PMID 19309400·Histopathology·2009
8-other
Identification of leptomeningeal disease in aggressive B-cell non-Hodgkin's lymphoma: improved sensitivity of flow cytometry.
PMID 19224854·J Clin Oncol·2009
4-observational
Reduced-intensity conditioning allogeneic hematopoietic cell transplantation using oral fludarabine as part of the conditioning regimen.
PMID 19148841·Cytotherapy·2009
4-observational
Study of kidney function impairment after reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation. A single-center experience.
PMID 19135939·Biol Blood Marrow Transplant·2009
8-other
Paraffin-based 6-gene model predicts outcome in diffuse large B-cell lymphoma patients treated with R-CHOP.
PMID 18445689·Blood·2008
8-other
Activation of the NF-kappaB signalling pathway in diffuse large B-cell lymphoma: clinical implications.
PMID 18983609·Histopathology·2008
8-other
Intensive chemotherapy (high-dose CHOP/ESHAP regimen) followed by autologous stem-cell transplantation in previously untreated patients with peripheral T-cell lymphoma.
PMID 18303032·Ann Oncol·2008
3-trial
High clinical and molecular response rates with fludarabine, cyclophosphamide and mitoxantrone in previously untreated patients with advanced stage follicular lymphoma.
PMID 18223288·Haematologica·2008
3-trial
Fludarabine, cyclophosphamide, and mitoxantrone as initial therapy of chronic lymphocytic leukemia: high response rate and disease eradication.
PMID 18172266·Clin Cancer Res·2008
3-trial
NK cells stimulated with IL-15 or CpG ODN enhance rituximab-dependent cellular cytotoxicity against B-cell lymphoma.
PMID 17959301·Exp Hematol·2008
8-other
Early clinical impact of iron overload in stem cell transplantation. A prospective study.
PMID 17279415·Ann Hematol·2007
3-trial
Prospective phase II trial of extended treatment with rituximab in patients with B-cell post-transplant lymphoproliferative disease.
PMID 18024397·Haematologica·2007
3-trial
Activation-associated phenotype of CD3 T cells in acute graft-versus-host disease.
PMID 16792671·Clin Exp Immunol·2006
8-other
Encouraging results with inolimomab (anti-IL-2 receptor) as treatment for refractory acute graft-versus-host disease.
PMID 17085306·Biol Blood Marrow Transplant·2006
8-other
Membrane PKC-beta 2 protein expression predicts for poor response to chemotherapy and survival in patients with diffuse large B-cell lymphoma.
PMID 16830142·Ann Hematol·2006
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 400 ALTAIR PKWY STE 3100
WESTERVILLE, OH 43082 - Phone
- (614) 899-2700
Quick Facts
- NPI
- 1386681443
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 26
- Publications
- 20
Are you this provider?
Claim Your Profile